Tristan Pascart,Emmanuel Drouin
Tristan Pascart
Ulrike Steffen,Koray Tascilar,Milena Santopietro et al.
Ulrike Steffen et al.
Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumab [0.03%]
Ixekizumab治疗活动性银屑病和肌腱炎相关型幼年特发性关节炎（COSPIRIT-JIA）：一项多中心、开放标签、持续16周的贝叶斯试验，包括与阿达木单抗进行随机对照的参考组
Athimalaipet V Ramanan,Nicolino Ruperto,Ivan Foeldvari et al.
Athimalaipet V Ramanan et al.
Background: Juvenile psoriatic arthritis and enthesitis-related arthritis are two categories of juvenile idiopathic arthritis (JIA). Despite available treatments including non-steroidal anti-inflammatory drugs, glucocorti...
COSPIRIT-JIA: considering biologic choices in juvenile spondyloarthritis [0.03%]
COSPIRIT-JIA：针对幼年型脊柱关节炎的生物制剂选择考虑因素
Matthew L Stoll,Maria I Danila
Matthew L Stoll
Paediatric rheumatology care in Europe: setting children and adolescents into focus [0.03%]
欧洲儿科风湿病护理：关注儿童和青少年患者
Dirk Foell,Marija Jelusic,Erdal Sag et al.
Dirk Foell et al.
Despite major scientific advances, delivering high-quality care for children with inflammatory rheumatic and musculoskeletal diseases remains challenging. The field of paediatric rheumatology lies at the intersection of different discipline...
Correction to Lancet Rheumatol 2026; published online Jan 21. https://doi.org/10.1016/S2665-9913(25)00284-X [0.03%]
柳叶刀风湿病学2026；发表于2023年1月21日在线出版物。https://doi.org/10.1016/S2665-9913(25)00284-X 的勘误表
Published Erratum
The Lancet. Rheumatology. 2026 Mar;8(3):e168. DOI:10.1016/S2665-9913(26)00047-0 2026
The Lancet Rheumatology
The Lancet Rheumatology
Anti-BCMA CAR T-cell for IgG4-related disease: is this necessary? [0.03%]
抗BCMA的CAR-T细胞治疗IgG4相关性疾病：有必要吗？
Paul Dalmas,Lionel Galicier,Mikael Ebbo et al.
Paul Dalmas et al.
Anti-BCMA CAR T-cell for IgG4-related disease: is this necessary? - Authors' reply [0.03%]
针对IgG4相关性疾病CAR-T细胞疗法的必要性——作者回复
Shaozhe Cai,Ziwei Hu,Yu Chen et al.
Shaozhe Cai et al.